A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
Top Cited Papers
- 1 January 2021
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 397 (10270) , 208-219
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 23 references indexed in Scilit:
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in RangeDiabetes Care, 2019
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical TrialsDiabetes Care, 2018
- Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trialThe Lancet, 2018
- Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesDiabetes Technology & Therapeutics, 2017
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 DiabetesJAMA, 2016
- Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of LifeDiabetes Technology & Therapeutics, 2015
- MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover TrialDiabetes Care, 2014
- Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes CampNew England Journal of Medicine, 2013
- MD-Logic Artificial Pancreas SystemDiabetes Care, 2010
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993